Rubra Medicaments Ltd.
BSE: 531099 | Sector: Others |
NSE: N.A. | ISIN Code: INE396H01019 |
BSE 00:00 | 25 Apr | Rubra Medicaments Ltd is not traded on BSE in the last 30 days |
NSE 05:30 | 01 Jan | Rubra Medicaments Ltd Not listed in NSE |
OPEN | 4.52 |
PREVIOUS CLOSE | 4.30 |
VOLUME | 2858 |
52-Week high | 4.52 |
52-Week low | 2.27 |
P/E | |
Mkt Cap.(Rs cr) | 2 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
About Rubra Medicaments Ltd.
Rubra Medicaments Limited was incorporated in the year 1991. The company does not have significant operations. Previously the company engaged in the manufacture and sale of pharmaceutical formulations. It is looking for alternate opportunities. The company is based in Hyderabad India. As of March 23 2010 Rubra Medicaments Limited operates as a subsidiary of Rubra Pharmaceuticals Limited....> More
Rubra Medicaments Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
2 | |
EPS - TTM | (![]() |
[*S] | - |
P/E Ratio | (X) | [*S] | - |
Face Value | (![]() |
10 | |
Latest Dividend | (%) | - | |
Latest Dividend Date | - | ||
Dividend Yield | (%) | 0.00 | |
Book Value / Share | (![]() |
[*S] | 1.06 |
P/B Ratio | (![]() |
[*S] | 4.06 |
Announcement
-
Certificate Under Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Reg
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
-
Related Party Disclosure For The Half Year Ended March 31 2022
-
Board Meeting Intimation for To Take On Record And Adopt The Standalone Audited Financial Results Of
-
Initial Disclosure To Be Made By An Entity Which Is Not A Large Corporate
Rubra Medicaments Ltd - Financial Results
Particulars (![]() |
Mar 2022 | Mar 2021 | % Chg |
Net Sales | 0.62 | 0.3 | 106.67 |
Other Income | - | ||
Total Income | 0.62 | 0.3 | 106.67 |
Total Expenses | 0.63 | 0.29 | 117.24 |
Operating Profit | -0.01 | 0.01 | -200 |
Net Profit | -0.02 | - | |
Equity Capital | 5.47 | 5.47 | - |
Rubra Medicaments Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Shamrock Indl. | 4.91 | -3.73 | 2.67 |
New Light Appare | 11.86 | -0.75 | 2.61 |
Chambal Brewer | 3.17 | 0.00 | 2.37 |
Oswal Yarns | 5.70 | 1.97 | 2.29 |
Promact Impex | 3.47 | 0.00 | 2.26 |
India Infras. | 7.98 | -5.00 | 2.23 |
Konndor Indust. | 3.73 | 0.00 | 2.06 |
Rubra Medicaments Ltd - SHAREHOLDING PATTERN
|
|
Rubra Medicaments Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | NA | NA | 0.34% | 0.34% |
1 Month | NA | NA | -4.47% | -4.66% |
3 Month | 40.98% | NA | -10.74% | -10.86% |
6 Month | NA | NA | -9.18% | -9.23% |
1 Year | NA | NA | 1.13% | 0.46% |
3 Year | 15.90% | NA | 33.31% | 32.75% |
Rubra Medicaments Ltd - STOCK STRENGTH
Today's Low/High | 4.30 | 4.52 | |
Week Low/High | 0.00 | 4.52 | |
Month Low/High | 0.00 | 4.52 | |
YEAR Low/High | 2.27 | 5.00 | |
All TIME Low/High | 0.96 | 79.00 |
Quick Links for Rubra Medicaments:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices